✦ LIBER ✦

Continuous cyclophosphamide, doxorubicin, vincristine, and prednisolone. A new, innovative protocol for diffuse aggressive lymphomas

✍ Scribed by Shripad D. Banavali; Suresh H. Advani; Ramakrishna Gopal; Sanjiv Agarwala; Katayun A. Dinshaw; Tapan K. Saikia; Suresh K. Pai; Purna Kurkure; Chandrika N. Nair; Maryaan Gonsalves; Shyam Shrivastava; Kanchan S. Nadkarni; Vasant R. Pai; T. K. Santhakumary; Alka T. Mazumdar

Book ID: 102668577
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 651 KB
Volume: 65
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900415)65:8<1704::aid-cncr2820650807>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic Chemotherapy with Vincristine,

Systemic Chemotherapy with Vincristine, Cyclophosphamide, Doxorubicin and Prednisolone Following Radiotherapy for Primary Central Nervous System Lymphoma: A Phase II Study

✍ Yuta Shibamoto; Keisuke Sasai; Natsuo Oya; Masahiro Hiraoka 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 40 KB

CyclOBEAP (cyclophosphamide, vincristine

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

✍ Nozomi Niitsu; Masataka Okamoto; Yasuaki Kuraishi; Shinobu Nakamura; Fumio Kodam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCN

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma

✍ John R. Durant Director; Virgil Loeb Jr.; Ronald Dorfman; Yick-Kwong Chan 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCN

1.3-Bis(2-chloroethyl)-1-nitrosourea(BCNU), cyclophosphamide, vincristine- and prednisone-(BCOP): A new therapeutic regimen for diffuse histiocytic lymphoma

✍ John R. Durant Director; Virgil Loeb Jr.; Ronald Dorfman; Yick-Kwong Chan 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

## Abstract Sixty‐seven evaluable patients with mixed cellular and histiocytic lymphomas, both nodular and diffuse, were treated with a combined drug regimen of BCNU, cyclophosphamide, vincristine, and prednisone administered for six monthly courses. Of 28 previously untreated patients with diffuse

Rituximab plus cyclophosphamide, doxorub

Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles

✍ Cunningham, David; Hawkes, Eliza A; Jack, Andrew; Qian, Wendi; Smith, Paul; Moun 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 429 KB

Phase II study of cyclophosphamide, doxo

Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508

✍ Kagami, Yoshitoyo; Itoh, Kuniaki; Tobinai, Kensei; Fukuda, Haruhiko; Mukai, Kiyo 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 308 KB